According to Precedence Research, the preterm birth and PROM testing market size is predicted to reach over US$ 2.21 billion by 2030 and growing at a CAGR of 3.2% from 2022 to 2030.
According to Precedence Research, the preterm birth and PROM testing market size is predicted to reach over US$ 2.21 billion by 2030 and growing at a CAGR of 3.2% from 2022 to 2030.
Growth Factors
According to the World Health Organization, around 15 million births are preterm annually across the globe. The preterm birth rate ranges from 5 to 8% in about 184 nations across the globe. Preterm births is a major cause of death in the children aged 5 years and below. The preterm birth and PROM testing facilitates the early detection of the fetal membrane rapture among the pregnant women and the necessary treatment can be provided on time to the women, thereby eliminating the risks of preterm birth. The increasing awareness among the population about the availability of preterm and PROM testing and its benefits is significantly boosting the growth of the global preterm and PROM testing market. The surging penetration of the specialty diagnostic labs that caters the services related to pregnancy and gynecology has significantly fostered the market growth in the past years.
Get the sample copy of report@ https://www.precedenceresearch.com/sample/1281
Report Highlights:
- On the basis of test type, the ultrasound was the leading segment in that accounted for around 32% of the market share in 2020. The huge demand for the ultrasound for producing the images of the developing fetus in the womb and its diagnosis has fueled the growth of the ultrasound segment. Moreover, ultrasound is the most common type of test that offers safe, non-invasive, cost-effective, and faster results features, which has led to the dominance of this segment across the globe.
- Depending on the end-user, the diagnostic laboratories segment garnered a market share of around 45% and dominated the global preterm and PROM testing market in 2020. This growth is attributed to the increased penetration of the diagnostic laboratories in the developed and developing markets across the globe. Moreover, the rising adoption of the services of the fertility clinics has fueled the demand for the PROM testing among the pregnant women to ensure safe delivery of its fetus.
- The global preterm and PROM testing market was dominated by North America, which accounted for a market share of 38% in 2020. North America is characterized by the increased healthcare expenditure, availability of favorable reimbursement policies, increased consumer awareness regarding preterm birth, and increased demand for the early diagnosis. As per the US CDC, there were around 10% of the preterm births in US in 2019 and around 17% of the preterm babies dies of low birth weight. The rising adoption of the advanced and digital technologies in the diagnostic centers is expected to sustain the position of North America in the global preterm and PROM testing market.
- The developing regions like Asia Pacific and Africa are expected to register the highest CAGR during the forecast period. The increasing cases of preterm birth in these developing regions is expected to propel the demand for the preterm birth and PROM testing. According to the World Health Organization, South Asia and Africa accounts for over 60% of the preterm births across the globe. The surging awareness regarding the benefits of PROM testing, rising disposable income, increasing healthcare expenditure, and growing penetration of diagnostic labs in the region are the major growth drivers.
Ask here for customization study@ https://www.precedenceresearch.com/customization/1281
Future of Preterm Birth and PROM Testing Market
The various digital technologies like artificial intelligence, cloud computing, internet of medical things, and augmented reality are gaining rapid traction and adoption in the diagnostic centers that can help in the faster and accurate production of test results and can be easily stored and accessed remotely. The increasing investments in the adoption of the latest technologies is expected to augment the market growth in the foreseeable future.
COVID-19 Impact Analysis:
- The outbreak of the COVID-19 pandemic in 2020 had a positive impact on the global preterm birth and PROM testing market.
- As per the CDC, the pregnant women, infected with the COVID-19 disease, were at higher risks of preterm delivery. This resulted in the spike in the demand for the preterm birth and PROM testing.
- The increased adoption of the digital technologies facilitated in the remote access to the test results and facilitated in the 24/7 access to the consultants.
- The remote patient monitoring systems provided by the telehealth platforms supported the growth of the preterm birth and prom testing market during the pandemic.
Key Developments in the Marketplace:
- In April 2018, QIAGEN received the FDA approval for its new point of care test product named PartoSure, which helped in the identification of the preterm labor symptoms among the pregnant women.
Segments Covered in the Report
By Test Type
- Ultrasound
- Biochemical Markers
- Pelvic Exam
- Nitazine Test
- Uterine Monitoring
- Pooling
- Ferning Test
- Others
By End User
- Diagnostic Laboratories
- Hospitals
- Others
By Geography
- North America
- Europe
- Asia Pacific
- MEA
- Rest of the World
Click Here to View Full Report Table of Contents
Buy this Research Report@ https://www.precedenceresearch.com/checkout/1281
You can place an order or ask any questions, please feel free to contact at sales@precedenceresearch.com | +1 9197 992 333